Last reviewed · How we verify

NCT07084103

Effectiveness of a Psychosocial Support Intervention for Women Diagnosed With Fetal Anomaly

Recruiting now NA Last updated 24 July 2025
What this trial tests

NA trial testing Psychosocial Support Intervention in Fetal Diseases in 64 participants. Currently enrolling.

Timeline
1 April 2025
Primary endpoint
30 September 2025
31 March 2026

Quick facts

Lead sponsorSakarya University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment64
Start date1 April 2025
Primary completion30 September 2025
Estimated completion31 March 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sakarya University

Who can join

18 and older, female only, with Fetal Diseases or Congenital Abnormalities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effectiveness of a psychosocial support intervention for women diagnosed with fetal anomaly. A randomized controlled trial design will be used, and women diagnosed with fetal anomaly will be included as participants. The intervention group will receive a structured psychosocial support program, while the control group will receive routine care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Psychosocial Support Intervention

Trials testing the same drug.

Other Sakarya University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07084103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing